Withdraw civil service pay guidance or face legal action, FDA warns
The FDA yesterday, alongside PCS and Prospect, instructed our lawyers to write to the Minister for the Cabinet Office David Lidington to request that the Government withdraws the civil service pay guidance and undertakes a process of appropriate consultation.
Given the headlong rush of some employers to impose the cap on civil service pay set out in the pay guidance, we have given ministers until 4pm on Thursday 19 July to respond. In the absence of an appropriate response we will be issuing proceedings for Judicial Review.
FDA General Secretary Dave Penman, PCS General Secretary Mark Serwotka and Prospect General Secretary Mike Clancy have issued a joint statement, which can be viewed here.
Commenting on the possibility of Judicial Review, FDA General Secretary Dave Penman said:
“This is not a decision we have taken lightly. The involvement of the courts in industrial relations practice is usually a sign of failure, that is certainly the case here.
“We have tried every reasonable approach to engage with ministers sensibly but have been rebuffed at every turn.
“They must now recognise that they have one last chance to do what every progressive employer should: engage those that represent their staff in a meaningful way for mutual benefit. If not, we remain ready and willing to act.”
Notes for editors
- The FDA is the union for senior managers and professionals in public service, representing more than 18,000 members at grades HEO and above. Membership includes senior civil servants, government policy advisors, prosecutors, diplomats, tax professionals, economists, solicitors and other professionals working across the Government and the NHS.
- The FDA (formerly the First Division Association) should be referred to simply as "The FDA" and can be described as "the senior public servants' union".
- The FDA can be found on Twitter @FDA_union. General Secretary Dave Penman tweets as @FDAGenSec.
- For more information contact FDA Communications Officer Tommy Newell on 020 7401 5588 or 07738 729 145.
- The joint statement from FDA General Secretary Dave Penman, PCS General Secretary Mark Serwotka and Prospect General Secretary Mike Clancy can be viewed here.
Latest News from
Scottish Government doesn’t truly value the work of FDA members13/12/2018 13:33:00
FDA National Officer Allan Sampson yesterday responded to the announcement of the Scottish Government’s public sector pay policy.
Standards Committee response: FDA raises concerns MPs may "kick Dame Laura's recommendations into the long grass"11/12/2018 13:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons Committee on Standards initial proposals following the Dame Laura Cox report.
Depression, breakdowns and departments under pressure: the FDA finds the real impact of unsustainable workloads in the civil service07/12/2018 16:10:00
Excessive working hours culture is decreasing public sector productivity and negatively impacting the health and wellbeing of civil servants, an FDA study has found.
New harassment inquiry must not delay implementation of Dame Laura Cox’s recommendations, says FDA07/12/2018 10:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the announcement that Gemma White QC has been appointed to conduct an independent inquiry into the bullying and harassment of MPs’ parliamentary staff.
New harassment inquiry must not delay implementation of Dame Laura Cox’s recommendations, says FDA06/11/2018 16:25:00
FDA Assistant General Secretary Amy Leversidge responded to the announcement that Gemma White QC has been appointed to conduct an independent inquiry into the bullying and harassment of MPs’ parliamentary staff
FDA welcomes important, if overdue, House of Commons Commission decision26/10/2018 15:15:00
The FDA welcome the House of Commons Commission’s important, if overdue, decision to implement reform off the back of Dame Laura Cox’s inquiry into bullying and harassment in the House of Commons.
FDA welcome House of Commons Commission's "important, if overdue" decision25/10/2018 14:25:00
FDA Assistant General Secretary Amy Leversidge yesterday responded to the House of Commons Commission’s decision to implement Dame Laura Cox’s recommendations in full.
House of Commons must not water down recommendations of harassment inquiry, FDA warns24/10/2018 13:10:00
On 24 October 2018, the House of Commons Commission will meet to consider the Dame Laura Cox inquiry into systemic bullying, harassment and sexual harassment.